CNSP News and Press, CNS Pharmaceuticals Inc. From 07/28/21

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system. Over recent months, the company has achieved several milestones demonstrating its operational, f...

Researchers from Arizona State University are conducting a study on the life cycle of stem cells. The study may be useful in the development of new techniques for treating brain cancer. The research was reported in the “Molecular Systems Biology” journal. Assistant profes...

CNS Pharmaceuticals (NASDAQ: CNSP) , a pharmaceutical company enthusiastically pursuing enrollment of about 243 brain cancer patients in a clinical trial designed to analyze the efficacy and safety of its lead drug candidate, was selected to be added to the Russell 2000 Index effective June...

CNS Pharmaceuticals has been granted FDA Fast Track Designation for Berubicin due to the serious unmet medical need for new GBM treatments Enrollment into the potentially pivotal study for Berubicin and glioblastoma multiforme (“GBM”) in adults is already underway CNS Ph...

A recent study by the St. Jude Children’s Research Hospital and the School of Medicine at the Washington University in St. Louis proposes that young patients with an average risk medulloblastoma can, after a six-week radiation treatment regimen, undergo a radiation boost to a smal...

3 Hot Penny Stocks to Add to Your Watchlist Right Now While trading penny stocks has not been ideal for the latter half of 2021, it looks like things could be turning around. This is marked by higher than average volume, and many penny stocks jumping significantly in value. But, it&...

Tempest Therapeutics (TPST) +141%.Mer Telemanagement Solutions (MTSL) +56%.Celldex Therapeutics (CLDX) +41% on early-stage data for CDX-0159 in skin condition.SGOCO Group (SGOC) +38%.Antelope Enterprise Holdings (AEHL) +30%.Cemtrex (CETX) +19%.Carver Bancorp (CARV) +15%.Park City Gr...

VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “ Company ” or “ WPD ”) a clinical-stage pharmaceutical company, is pleased to announce that CNS Pharmaceuticals Inc. (“ CNS ...

Researchers have made a new discovery in a fatal and aggressive childhood cancer known as Ewing sarcoma, which could possibly help hinder the spread of cancer cells. This new discovery offers new insights into what causes the process that enables cancer cells to survive as they travel thro...

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today provided a business update. Among the highlights, the company reported on its continued prog...